3C
AGN

361 Capital’s Allergan plc AGN Stock Holding History

361 Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,477
Closed -$662K – 448
2018
Q3 		$662K Sell
3,477
-9,644
-74% -$1.77M 0.14% 263
2018
Q2 		$2.19M Buy
+13,121
New +$2.11M 0.5% 28
2017
Q3 		– Sell
-28,380
Closed -$6.9M – 309
2017
Q2 		$6.9M Buy
28,380
+1,475
+5% +$347K 1.16% 36
2017
Q1 		$6.43M Buy
+26,905
New +$6.27M 1.38% 31

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

361 Capital's AGN Position: Q4 2018 in Review

361 Capital sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 3,477 shares — an estimated $662K sold.

361 Capital first reported a position in AGN in Q1 2017 and held it in 4 quarters. The position peaked at $6.9M in Q2 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • 361 Capital reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • 361 Capital sold 3,477 Allergan plc shares in Q4 2018, an estimated $662K.
  • 361 Capital first reported a position in Allergan plc in Q1 2017 and held it in 4 quarters.
  • 361 Capital's Allergan plc position peaked at $6.9M in Q2 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on 361 Capital's 13F filing for Q4 2018, filed 8 Feb 2019.